Cyclic FEE Peptide Improves Human Sperm Movement Parameters without Modification of Their Energy Metabolism.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
19 Oct 2021
Historique:
received: 30 09 2021
revised: 14 10 2021
accepted: 15 10 2021
entrez: 23 10 2021
pubmed: 24 10 2021
medline: 15 12 2021
Statut: epublish

Résumé

Cyclic fertilin peptide (cFEE: phenylalanine, glutamic acid; glutamic acid) improves gamete interaction in humans. We investigate whether it could be via improvement of sperm movement parameters and their mitochondrial ATP production. Sperm movement parameters were studied using computer-assisted sperm analysis (CASA) in sperm samples from 38 patients with normal sperm in medium supplemented with cyclic fertilin against a control group. Sperm mitochondrial functions were studied using donor's sperm, incubated or not with cFEE. It was evaluated by the measurement of their ATP production using bioluminescence, their respiration by high resolution oxygraphy, and of mitochondrial membrane potential (MMP) using potentiometric dyes and flow cytometry. cFEE significantly improved sperm movement parameters and percentage of hyperactivated sperm. Impact of inhibitors showed OXPHOS as the predominant energy source for sperm movement. However, cFEE had no significant impact on any of the analyzed mitochondrial bioenergetic parameters, suggesting that it could act via a more efficient use of its energy resources.

Identifiants

pubmed: 34681924
pii: ijms222011263
doi: 10.3390/ijms222011263
pmc: PMC8539654
pii:
doi:

Substances chimiques

Peptides, Cyclic 0
Adenosine Triphosphate 8L70Q75FXE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Agence Nationale de la Recherche
ID : ANR-17-CE18-0005-02

Références

Cell. 1984 Aug;38(1):101-8
pubmed: 6432338
Int J Androl. 2005 Apr;28(2):65-73
pubmed: 15811066
Int J Androl. 2011 Jun;34(3):247-55
pubmed: 20546047
Microsc Res Tech. 2003 May 1;61(1):103-15
pubmed: 12672126
Hum Reprod. 2002 May;17(5):1257-65
pubmed: 11980749
Chem Biol. 1999 Jan;6(1):1-10
pubmed: 9889149
Exp Cell Res. 1998 Jun 15;241(2):384-93
pubmed: 9637780
Am J Reprod Immunol. 1996 Jun;35(6):541-51
pubmed: 8792938
Andrologia. 2012 Apr;44(2):136-41
pubmed: 21714802
Methods Mol Biol. 2012;810:25-58
pubmed: 22057559
Mol Reprod Dev. 1997 Mar;46(3):363-9
pubmed: 9041139
Hum Reprod. 2004 Oct;19(10):2267-76
pubmed: 15256505
Urology. 2012 Apr;79(4):809-14
pubmed: 22381250
Int J Mol Sci. 2020 Nov 11;21(22):
pubmed: 33187358
Dev Dyn. 2010 Mar;239(3):773-83
pubmed: 20151413
Biochim Biophys Acta. 1998 Sep 16;1404(3):393-404
pubmed: 9739168
Hum Reprod Update. 2004 Sep-Oct;10(5):387-99
pubmed: 15218008
Biol Reprod. 2006 Aug;75(2):270-8
pubmed: 16687649
J Androl. 2001 Jul-Aug;22(4):680-95
pubmed: 11451366
Am J Reprod Immunol. 2008 Jan;59(1):2-11
pubmed: 18154591
Fertil Steril. 2009 May;91(5 Suppl):2110-5
pubmed: 18692807
Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):11830-5
pubmed: 10518536
J Cell Sci. 2009 Aug 1;122(Pt 15):2741-9
pubmed: 19596796
Neuromuscul Disord. 2007 May;17(5):368-75
pubmed: 17383182
Indian J Exp Biol. 2010 May;48(5):425-35
pubmed: 20795359
Immunol Lett. 1998 Apr;61(2-3):157-63
pubmed: 9657269
Science. 1998 Sep 18;281(5384):1857-9
pubmed: 9743500
Nat Cell Biol. 2007 Mar;9(3):235-42
pubmed: 17330112
J Clin Endocrinol Metab. 2008 Aug;93(8):3199-207
pubmed: 18492763
Mol Biol Cell. 2002 Dec;13(12):4343-54
pubmed: 12475957
J Biol Chem. 2000 Apr 21;275(16):11576-84
pubmed: 10766772
Hum Reprod. 1995 Apr;10(4):873-9
pubmed: 7650135
PLoS One. 2011 Mar 23;6(3):e18112
pubmed: 21448461
Int J Androl. 2011 Feb;34(1):2-13
pubmed: 20158539
Clin Chim Acta. 2000 Oct;300(1-2):97-105
pubmed: 10958866
BMC Dev Biol. 2007 Sep 12;7:102
pubmed: 17850654
Curr Top Dev Biol. 2007;77:3-19
pubmed: 17222698
J Histochem Cytochem. 1993 Aug;41(8):1247-51
pubmed: 8331289
Int J Androl. 2010 Feb;33(1):e180-6
pubmed: 19751363
J Biomed Opt. 2008 Jan-Feb;13(1):014002
pubmed: 18315360
J Cell Sci. 2012 Nov 1;125(Pt 21):4985-90
pubmed: 22946049
Hum Reprod. 2005 Dec;20(12):3452-8
pubmed: 16096325
Biophys J. 1993 Dec;65(6):2396-407
pubmed: 8312478

Auteurs

Nathalie Le Foll (N)

Institut Cochin, Université de Paris, INSERM, CNRS, 75014 Paris, France.
Service D'histologie, D'embryologie, Biologie de la Reproduction, AP-HP, Hôpital Cochin, 75014 Paris, France.

Jean-Christophe Pont (JC)

Institut Cochin, Université de Paris, INSERM, CNRS, 75014 Paris, France.

Audrey L'Hostis (A)

Institut Cochin, Université de Paris, INSERM, CNRS, 75014 Paris, France.
Service D'histologie, D'embryologie, Biologie de la Reproduction, AP-HP, Hôpital Cochin, 75014 Paris, France.

Thomas Guilbert (T)

Institut Cochin, Université de Paris, INSERM, CNRS, 75014 Paris, France.

Frédéric Bouillaud (F)

Institut Cochin, Université de Paris, INSERM, CNRS, 75014 Paris, France.

Jean-Philippe Wolf (JP)

Institut Cochin, Université de Paris, INSERM, CNRS, 75014 Paris, France.
Service D'histologie, D'embryologie, Biologie de la Reproduction, AP-HP, Hôpital Cochin, 75014 Paris, France.

Ahmed Ziyyat (A)

Institut Cochin, Université de Paris, INSERM, CNRS, 75014 Paris, France.
Service D'histologie, D'embryologie, Biologie de la Reproduction, AP-HP, Hôpital Cochin, 75014 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH